Tag:
Organon Biosciences
Latest Headlines
Latest Headlines
Dutch firm eyes buyout of Merck's Organon ops
Scenario: A drugmaker buys a smaller company, then merges with another pharma. It then moves to shut down many of the smaller companies' facilities. So what happens? In this case, a local firm tries
Merck delays closure of Dutch ops
Merck ( $MRK ) has extended until mid-February from Dec. 31 a deadline to determine the fate of some of its Dutch operations. And one possible alternative is the sale of the R&D site, Reuters
